These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7523237)

  • 61. [Effects of HS 6101 and rhG-CSF on Hematopoiesis Recovery of ICR Mice Injured by Cyclophosphamide].
    Xiong GL; Shen X; Liu XL; Yang M; Dai CL; Liu XY; Xing S; Yu ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1716-20. PubMed ID: 26708899
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recombinant granulocyte colony-stimulating factor induces production of human neutrophil peptides in lung cancer patients with neutropenia.
    Ashitani J; Nakazato M; Mukae H; Taniguchi H; Date Y; Matsukura S
    Regul Pept; 2000 Nov; 95(1-3):87-92. PubMed ID: 11062337
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of rhG-CSF, 5-fluorouracil and extramedullary irradiation on murine megakaryocytopoiesis in vivo.
    Scheding S; Media JE; Kraut M; Valdivieso M; Nakeff A
    Br J Haematol; 1994 Dec; 88(4):699-705. PubMed ID: 7529538
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
    Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical trial of recombinant granulocyte colony-stimulating factor for chemotherapy-induced neutropenia patients with oral cancer.
    Iwase M; Yoshiya M; Kakuta S; Nagumo M
    J Oral Maxillofac Surg; 1997 Aug; 55(8):836-40; discussion 841. PubMed ID: 9251612
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhancement of host defense by Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice.
    Hisadome M; Fukuda T; Terasawa M; Oe T; Takahata H; Goto K; Tsuru S; Nomoto K
    Int J Immunopharmacol; 1992 Oct; 14(7):1195-201. PubMed ID: 1280628
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of a Long-Acting Site-Specific PEGylated Murine GM-CSF Analog and Analysis of Its Hematopoietic Properties in Normal and Cyclophosphamide-Treated Neutropenic Rats.
    Cox GN; Lee JI; Rosendahl MS; Chlipala EA; Doherty DH
    Protein J; 2020 Apr; 39(2):160-173. PubMed ID: 32172395
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hematopoietic properties of granulocyte colony-stimulating factor/immunoglobulin (G-CSF/IgG-Fc) fusion proteins in normal and neutropenic rodents.
    Cox GN; Chlipala EA; Smith DJ; Carlson SJ; Bell SJ; Doherty DH
    PLoS One; 2014; 9(3):e91990. PubMed ID: 24637521
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients.
    Jiang Y; Zhang J; Zhong J; Liao H; Zhang J; Liu Y; Liang Y; Li H
    BMC Cancer; 2023 Jul; 23(1):702. PubMed ID: 37495949
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats.
    Scholz M; Engel C; Apt D; Sankar SL; Goldstein E; Loeffler M
    Cell Prolif; 2009 Dec; 42(6):823-37. PubMed ID: 19780759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on cytotoxicity of PSK-induced peritoneal polymorphonuclear leukocytes (PMNs).
    Kato H; Inoue M; Yamamura Y; Kawahito Y; Mukai S; Sugino S; Kondo M
    Biotherapy; 1992; 5(3):177-86. PubMed ID: 1384634
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
    Hattori K; Orita T; Oheda M; Tamura M; Ono M
    In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reduction of the leukemogenic potential of malignant murine leukemic cells by in vivo treatment with recombinant human granulocyte colony-stimulating factor.
    Tamura M; Orita T; Oh-eda M; Hasegawa M; Nomura H; Maekawa T; Abe T; Ono M
    Leuk Res; 1993 Jul; 17(7):593-600. PubMed ID: 7686992
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reproducible preparation and effective separation of PEGylated recombinant human granulocyte colony-stimulating factor with novel "PEG-pellet" PEGylation mode and ion-exchange chromatography.
    Yun Q; Yang RE; Chen T; Bi J; Ma G; Su Z
    J Biotechnol; 2005 Jul; 118(1):67-74. PubMed ID: 15904987
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia.
    Shitara T; Yugami S; Ijima H; Sotomatu M; Kuroume T
    Am J Hematol; 1994 Jan; 45(1):58-62. PubMed ID: 7504401
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
    Zou D; Guo M; Zhou Q
    BMC Cancer; 2021 Jun; 21(1):661. PubMed ID: 34078317
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PEG-rhG-CSF for prophylaxis of neutropenia after chemotherapy in patients with non-small cell lung cancer: A multicenter, prospective, randomized study.
    Sun XS; Wang Z; Ren SH; Zhang HL; Liu LJ; Du HB; Liu XW; Liu JF
    Thorac Cancer; 2022 Sep; 13(17):2429-2435. PubMed ID: 35859328
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of recombinant human granulocyte colony-stimulating factor on the growth potential of two murine myeloid leukemias.
    Kabaya K; Obuchi M; Kuwaki T; Shibuya K; Watanabe M; Nemoto K; Yoshida K; Kusaka M; Inoue T; Seki M
    Leuk Res; 1996 Jan; 20(1):27-35. PubMed ID: 8632675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.